Webinar: Advantages bringing early phase trials to North AmericaSupported by: Published: 27 September 2023Share this post0 Share via Facebook Like Twitter Pinterest LinkedIn Digg Del Tumblr VKontakte Print Email Reddit Buffer Love This Weibo Pocket Xing Odnoklassniki iconOdnoklassniki WhatsApp Meneame Blogger Amazon Yahoo Mail Gmail AOL Newsvine HackerNews Evernote MySpace Mail.ru Viadeo Line Flipboard Comments Yummly SMS Viber Telegram Subscribe Skype Facebook Messenger Kakao LiveJournal Yammer Edgar Fintel Mix Instapaper Copy LinkWatch Altasciences’ on-demand webinar to learn the key advantages and differences of conducting early phase clinical trials in North America.In this complimentary webinar, you’ll discover the benefits of conducting FIH trials in Canada, including quicker regulatory approvals.You will learn about:Ensuring timely FIH clinical trials when planning your early phase drug development strategyUtilizing foreign clinical trials for U.S. FDA drug submissions and approvalsDifferences in the quality and nonclinical data submission requirements to gain EMA, FDA, and Health Canada approval to conduct FIH Phase I trials.
